Lingyi Itech (002600.SZ) plans to indirectly increase its investment in Vietnam's Guanghong by 11.025 million US dollars to meet business development needs.
Leadership Wisdom Manufacturing (002600.SZ) Announcement, the company announced that in order to meet the needs of its joint venture subsidiary Guanghong (Vietnam) Technology Co., Ltd. (...)
Lingyi Itech (002600.SZ) announced that in order to meet the development needs of the AI terminal hardware business of its equity investment subsidiary Guanghong (Vietnam) Technology Co., Ltd. (referred to as "Vietnam Guanghong"), it plans to jointly increase its capital by $45 million through DBG Technology (Investment) Co., Ltd. (referred to as "DBG Technology Investment") with other shareholders of DBG Technology. The company will indirectly increase its capital by $11.025 million, while other shareholders will indirectly increase their capital by $33.975 million.
It is reported that the purpose of this capital increase for Vietnam Guanghong is to meet the business development needs of Vietnam Guanghong and further enhance its intelligent manufacturing, business expansion, and technological innovation capabilities in the AI terminal hardware-related business.
Related Articles

US Stock Market Move | Popular Chinese concept stocks collectively rose sharply, with New Oriental Education & Technology Group, Inc. Sponsored ADR (EDU.US) jumping more than 8%.

US Stock Market Move | Gold stock continues to strengthen, Kinross Gold Corporation (KGC.US) rises more than 7%

US Stock Market Move | Omeros Corporation (OMER.US) soars 150% following asset purchase and license agreement with Novo Nordisk A/S Sponsored ADR Class B.
US Stock Market Move | Popular Chinese concept stocks collectively rose sharply, with New Oriental Education & Technology Group, Inc. Sponsored ADR (EDU.US) jumping more than 8%.

US Stock Market Move | Gold stock continues to strengthen, Kinross Gold Corporation (KGC.US) rises more than 7%

US Stock Market Move | Omeros Corporation (OMER.US) soars 150% following asset purchase and license agreement with Novo Nordisk A/S Sponsored ADR Class B.
